Best Cheap Biotech Stocks
Discover investment opportunities in Best Cheap Biotech Stocks using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Cheap Biotech Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Cheap Biotech Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Cheap Biotech Stocks using our Smart AI Filter.
6 stocks found for "Best Cheap Biotech Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
1.43 Risk measure | ±100.0% Price volatility | -1.1 Valuation | 0.00% Annual yield | |||
0.77 Risk measure | ±68.2% Price volatility | -1.5 Valuation | 0.00% Annual yield | |||
1.01 Risk measure | ±62.0% Price volatility | 25.4 Valuation | 0.00% Annual yield | |||
1.11 Risk measure | ±75.1% Price volatility | -18.3 Valuation | 0.00% Annual yield | |||
0.97 Risk measure | ±72.8% Price volatility | -79.7 Valuation | 0.00% Annual yield | |||
0.12 Risk measure | ±100.0% Price volatility | — Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Adma Biologics (ADMA) concluded the recent trading session at $17.13, signifying a +2.39% move from its prior day's close.
Read moreMAMA, BSET and AMRN meet breakout criteria with strong earnings growth and prices near 52-week highs.
Read moreClover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Read moreThe heavy selling pressure might have exhausted for Cassava Sciences (SAVA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read moreCassava Sciences Inc. SAVA on Tuesday shared topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate Alzheimer's disease.
Read moreVistaGen Therapeutics, Inc. (VTGN) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $0.22 per share a year ago.
Read more